Thomas Gantt

Thomas Gantt is a seasoned professional in quality control and assurance, currently serving as a Senior Quality Control Manager and Global QA/QC Technical Support Manager at Novavax since April 2021. In this role, Thomas is responsible for the development of analytical method validation strategies and the review and approval of related protocols and reports. Previously held positions include Quality Control Manager and Supervisor, overseeing operational and technical efforts in potency testing for the Nano HA SARS-CoV-2 Combination Drug Product at Novavax, and served as a Quality Control Supervisor at Catalent Pharma Solutions, managing a team focused on analytical testing for various drug substances. Thomas’s career encompasses significant experience in both the biopharmaceutical and cell therapy sectors, with early roles in analytical assays and stability testing. Educational qualifications include Associate degrees in General Studies and Biotechnology from Montgomery College.